Sept. 30, 2022 Price forecast | 2 weeks: -0.15% | 1 month: -1.06% | 3 months: 36.13% | Premium Forecast


CELZ stock forecast

Our latest prediction for Creative Medical Technology Holdings Inc's stock price was made on the Sept. 30, 2022 when the stock price was at 0.44$.

In the short term (2weeks), CELZ's stock price should underperform the market by -0.15%. During that period the price should oscillate between -13.20% and +13.59%.

In the medium term (3months), CELZ's stock price should outperform the market by 36.13%. During that period the price should oscillate between -32.85% and +47.21%.

Create a solid portfolio with CELZ

Add CELZ to your portfolio and optimize it!


About Creative Medical Technology Holdings Inc

Creative Medical Technology Holdings, Inc. is a commercial stage biotechnology company committed to improving patient lives in the areas of Immunology, Urology, Neurology and Orthopedics. Creative Medical Technology Holdings, Inc. is focused on regenerative medical solutions for unmet Immunological, Urological, Neurological and Orthopedic needs. The company has developed an extensive intellectual property portfolio utilizing stem cells and interrelated technologies for the treatment of multiple indications and commercialized complete patented and trademarked protocols for erectile dysfunction under the CaverStem® brand and the FemCelz® brand for the treatment of female sexual dysfunction. Its StemSpine® technology has undergone a pilot study and is prepared for commercialization of it’s autologous (patients own stem cells) program with the vision of progressing it’s patented allogenic (donor cells) program through FDA clinical trial. CELZ is also breaking new ground with its ImmCelz® technology for the treatment of multiple indications. Its team consists of leading physicians and scientists specializing in regenerative medicine. Its "science-first" approach to procedures ensures that all of its technology is proven to be both safe and effective.

At the moment the company doesn't generate any revenue.

On its last earning announcement, the company reported a loss of -0.42$ per share.

The book value per share is 1.65$

Creative Medical Technology Holdings Inc website


Three months stock forecastSept. 30, 2022


Financials

Revenue USD Gross Margin Operating Income Operating Margin Net Income Earnings Per Share Dividends Payout Ratio Shares Book Value Per Share Operating Cash Flow Cap Spending Free Cash Flow
- 54.81% -5M -3948.46% -7M -0.42 - - 14M 1.65 - - -